Abstract-Drug-target interaction studies are important because they can predict drugs' unexpected therapeutic or adverse side effects. In silico predictions of potential interactions are valuable and can focus effort on in vitro experiments. We propose a prediction framework that represents the problem using a bipartite graph of drug-target interactions augmented with drug-drug and target-target similarity measures and makes predictions using probabilistic soft logic (PSL). Using probabilistic rules in PSL, we predict interactions with models based on triad and tetrad structures. We apply (blocking) techniques that make link prediction in PSL more efficient for drug-target interaction prediction. We then perform extensive experimental studies to highlight different aspects of the model and the domain, first comparing the models with different structures and then measuring the effect of the proposed blocking on the prediction performance and efficiency. We demonstrate the importance of rule weight learning in the proposed PSL model and then show that PSL can effectively make use of a variety of similarity measures. We perform an experiment to validate the importance of collective inference and using multiple similarity measures for accurate predictions in contrast to non-collective and single similarity assumptions. Finally, we illustrate that our PSL model achieves state-of-the-art performance with simple, interpretable rules and evaluate our novel predictions using online data sets.
INTRODUCTION
T HE cost of successful novel chemistry-based drug development often reaches billions of dollars, and the time to introduce the drug to market often comes close to a decade. Most new compounds fail during clinical trials or show adverse side effects. Because of the high failure rate of drugs during this process, the trial phase is often referred to as the "valley of death" [1] .
Most drugs 1 affect multiple targets, and Polypharmacology, the study of such interactions, is an area of growing interest [2] . These multi-target interactions potentially result in both unintentional therapeutic and adverse side effects. Predicting side effects during the drug developmental phase can reduce the high cost of clinical trials and is crucial for the commercial success of new drugs. Moreover, due to the high cost and low success rate of novel drug development, pharmaceutical companies are particularly interested in drug repositioning or repurposing, which involves finding new therapeutic effects of pre-approved drugs.
Sildenafil-originally developed for pulmonary arterial hypertension treatment-is a famous drug repurposing example. In clinical trials, it was discovered by chance to have a side effect of treating erectile dysfunction in men, and it was eventually re-branded as Viagra [3] .
Drug-target interaction identification is an essential step of drug repurposing and drug adverse effect prediction. In vitro identification of drug-target associations is a laborintensive and costly procedure. Hence, in silico prediction methods are promising approaches for focusing in vitro investigations [4] .
There are several methods to model the drug-target interaction prediction task [5] , many of which use a network representation [6] . We can construct a bipartite interaction network where nodes represent drugs and targets, and edges denote interactions. Drug-drug and target-target similarities can augment this network on each side. Data from multiple publicly accessible data sets can be integrated toward building these networks [7] . The similarities between drugs and between targets have different semantics. For example, targets can have similarity measures based on their sequences and their ontology annotations [8] . Fig. 1 shows a schematic overview of a drug-target interaction network.
A link prediction method can predict new potential drug-target interactions in this setting [9] , [10] . However, traditional link prediction methods often ignore the multirelational characteristics of this drug-target interaction network (i.e., nodes and edges with different semantics) or make oversimplifying assumptions that neglect key, interdependent phenomena during prediction.
The structure of the network and the multi-relational aspects make it challenging to convert such knowledge into the (flat) data formats that are typically used with standard prediction algorithms. Attempts to make such conversions often rely on potentially ad-hoc feature engineering approaches [8] , [11] . Such methods may sometimes yield good prediction performance, but they suffer from low interpretability and loss of information. Our approach is based on the premise that links depend on the similarities between their endpoints and on other interactions. Hence, a collective approach is more appropriate than standard machine learning models that make simplifying independence assumptions. As described in Section 5, in a collective setting, the presence or absence of interactions are studied interdependently.
In this paper we present a drug target prediction framework based on probabilistic soft logic (PSL) [12] , [13] . We reason collectively over the unknown interactions using a structured representation that captures the multirelational nature of the network. 2 We design a PSL model for drug-target interaction prediction that reasons over structured rules. We consider two types of structured rules, triad rules and tetrad rules, and consider a variety of similarity metrics. We propose a blocking method to manage the large computational cost of inference in this task and perform experimental studies on different aspects of link prediction in the drug-target interaction domain with this model. We compare the relative improvement provided by each type of structural rule and find that triad-based rules enable more accurate predictions. We also experiment with the effect of using different similarity metrics and show that combining all similarity metrics in a single probabilistic model produces the most effective model. We additionally test the importance of collective inference in such models by comparing against an analogous model that makes independent predictions. Our PSL based solution outperforms the stateof-the-art drug-target interaction prediction method proposed by Perlman et al. [8] . We further validate that our PSL models can outperform Perlman et al. [8] on a set of new interactions that were not considered in the original evaluation of Perlman et al. [8] .
RELATED WORK
In the similarity ensemble approach (SEA), Keiser et al. [4] use ligands to predict interaction. They use ligands for target representation and chemical similarities between drugs and ligand sets as potential interaction indicators. In CMap, by Lamb et al. [16] , [17] , mRNA expressions are used to represent diseases, genes, and drugs. They compare up-and down-regulations of the gene-expression profiles from cultured human cells treated with bioactive molecules and provide cross-platform comparisons. They predict new potential interactions based on opposite-expression profiles of drugs and diseases. Chang et al. [18] , [19] proposed a method for predicting drug targets for a given phenotype predicting phenotypes given specific genetic perturbations.
A number of methods reason about network structures to predict interactions. Cockell et al. [3] describe how to integrate drugs, targets, genes, proteins, and pathways into a network for different tasks. They present a hypothesis that similar targets interact with the same drugs, and similar drugs tend to interact with the same targets. Lee et al. [7] describe drug repurposing, multi-agent drug development, and estimation of drug effects on target perturbations via network-based solutions.
Yildirim et al. [6] explain trends in the drug-discovery industry over time using a network-based analysis and show the effect of sequencing the genome on drug development. They also discuss different structural aspects of this network including preferential attachment and cluster formation.
Network-based approaches integrate drug-drug and target-target similarities extracted via different methods (e.g., SEA and CMap) with the drug-target interactions network. The following methods use a single similarity measure for drugs and targets to predict interactions: Cheng et al. [20] predict potential interactions using drug-drug and target-target similarities and a bipartite interaction graph. Using SIM-COMP [21] , they compute the 2D chemical drug similarities and sequence similarities for targets via the Smith-Waterman score. They use the following three link-prediction methods: drug-based similarity inference (DBSI)-only considering similarities between drugs; target-based similarity inference (TBSI)-only considering target similarities; network-based inference (NBI)-combining both similarities. Alaimo et al. [22] extend this approach by proposing a DT-hybrid method that integrates prior domain-dependent knowledge.
Yamanishi et al. [11] propose the following three methods for interaction prediction: a nearest neighbor approach; weighted k-nearest neighbors; and space integration. For the space integration method, they describe a genomic space, using the Smith-Waterman score for targets, and the SIM-COMP score for drugs. They propose a method to integrate drugs and targets in a unified latent pharmacological space, and they predict interactions in that space based on the proximity of drugs and targets. They separate out four categories of targets, namely enzymes, ion channels, GPCR, and nuclear receptors for their experiments. They also report that similar drugs tend to interact with similar targets and vise versa.
Bleakley and Yamanishi [23] extend this method and construct local models for graph inference. They classify each interaction twice and combine the results to provide a prediction. First, they build a classifier based on drugs and then 2. Our previous workshop papers [14] , [15] contain a preliminary version of part of this research.
based on targets. They use the similarities as the support vector machine (SVM) kernels. Extending this method, Mei et al. [24] propose to infer training data from neighbors' interaction profiles to make predictions for new drug or target candidate that do not have any interactions in the network. Wang and Zeng [25] propose a method based on restricted Boltzmann machines for drug-target interaction prediction.
More advanced methods predict interactions based on multiple similarities. Chen et al. [26] reason about the possibility of a drug-target interaction in relation with other linked objects. They use distance, shortest paths, and other topological properties in the network to assess the strength of a relation. They assign scores to paths between drugs and targets and combine path scores for each drug-target pair.
Perlman et al. [8] propose a feature-engineering method based on combinations of drug-drug and target-target similarities and use classification to predict interactions. They build their method based on five drug-drug and three target-target similarities. They evaluate their model using cross validation over three online data sets and validate their predication on a fourth data set. They show significant performance improvement over Bleakley and Yamanishi [23] and Yamanishi et al. [11] that only use one type of drugdrug and target-target similarities for prediction. To the best of our knowledge Perlman et al. [8] method is the state-ofthe-art mutli-similarity based approach for drug-target interaction prediction.
Gottlieb et al. [27] extend their method in [8] to drugdisease domain and propose a personalized medicine approach, representing diseases via their genetic signatures. This method can predict the most effective compound for a genetic signature of an unknown disease.
OUR MODEL
Our proposed drug-target prediction framework uses probabilistic soft logic [12] , [13] . In this section, we review PSL and present the logical rules that we use for drug-target interaction prediction.
Probabilistic Soft Logic
PSL uses syntax based on first-order logic as a templating language for probabilistic models over continuous variables. For example, a PSL rule can be of the following form:
w : P ðA; BÞ^QðB; CÞ ! RðA; CÞ;
where P , Q, and R are predicates, and A, B, and C are variables. For instance, P ðA; BÞ can be InteractsðD; T Þ where D represents a drug and T is a target. Predicates become instantiated with data, generating groundings (e.g., Interacts (acetaminophen, cox2)). Each grounding forms a ground atom, or logical fact, that has a soft-truth value in the range ½0; 1. In our PSL model for drug-target interaction, we represent drugs and targets as variables and specify predicates to represent different similarities and interactions between them. Then the rules encode domain knowledge about dependencies between these predicates. Since PSL uses continuous variables to represent the soft truth of atoms, its semantics are based on relaxations from Boolean logic. PSL uses the Lukasiewicz t-norm and co-norm to provide relaxations of the logical connectives AND (^), OR (_), and NOT (:) as follows:
A full assignment of soft-truth values to a set of ground atoms is called an interpretation (I) of that set. Using the above relaxations and the logical identity p ! q : p _ q, a ground instance of a rule r (r body À! r head ) is satisfied (i.e., IðrÞ ¼ 1) when Iðr body Þ Iðr head Þ.
PSL defines a probability distribution by quantifying a distance to satisfaction for each grounded instance of a rule. A rule's distance to satisfaction under interpretation I is calculated as follows:
The distance to satisfaction for all rules are used as features in a log-linear distribution, where the weights are nonnegative. The density function for the distribution is
where R is the set of ground rules, w r is the weight of rule r, p is a modeling parameter in f1; 2g, and Z is the normalization constant
Because each factor in this density function uses a hinge function (2) reminiscent of hinge-losses used in classification, PSL's probability distributions are instances of hingeloss Markov random fields (HL-MRFs). For HL-MRFs, inference of a most probable explanation (MPE), which finds the most probable interpretation given evidence (i.e., a given partial interpretation) is computed by maximizing the density function fðIÞ in Equation (3), subject to both the evidence and the equality and inequality constraints. For example, given a drug-target interaction network and interactions between some drugs and some targets, the goal of MPE inference is to output the most likely interactions between all other drugs and targets. Finding the most probable interpretation given a set of weighted rules reduces to solving a convex optimization problem and can be solved very efficiently [28] , [29] .
The PSL rule weights indicate how much an assignment is penalized if a rule is not satisfied. They are a measure of importance for each rule. We can set the weights based on prior domain knowledge or, if we have training data, we can learn the weights using a number of different training objective and learning algorithms [12] , [13] , [29] . In particular, the primary methods for weight learning are votedperceptron approximate maximum likelihood, maximum pseudo-likelihood, and large-margin estimation.
In this work, we use approximate maximum likelihood, which we review here. We seek to maximize the log-likelihood of the full data, including both the observed data and the training labels. We can do so using gradient ascent, where the gradient of the log-likelihood with respect to a weight w i is:
where R i is the set of ground rules parameterized with weight w i . This gradient is intractable to compute exactly because the expectation term enumerates all possible interpretations, so we approximate the expectation by the values at the MPE solution. This approximation-whose resulting algorithm can be interpreted as a form of structured perceptron-is effective in practice and has been used on various other structured models [30] , [31] .
PSL Model for Drug-Target Interaction
We design a PSL program using rules that capture domain knowledge about the drug-target interaction problem. Our rules model the idea that similarity among drugs may imply similar interactions with targets, and similarity among targets may imply similar interactions with drugs. We incorporate many types of similarities into a single joint probabilistic model, simultaneously reasoning about the various possible interactions. Triad-based rules. For drug-target interaction prediction, many established methods are based on triangles or triads between drugs and targets. These triads occur between two similar targets and a drug that interacts with both of them, or two similar drugs and a target that both drugs interacts with. The hypothesis is that similar targets tend to interact with the same drug and that similar drugs tend to interact with the same target [3] , [11] , [20] . Fig. 2 depicts the triad-based prediction of interactions for drugs and targets.
The following rules capture the triads shown in Figs. 2a and 2b respectively:
where T denotes a target, D indicates a drug, predicate SimilarTarget b represents a specific target-target similarity metric. For each similarity metric, we add an instance of rule (5) to the PSL model. Our model is capable of integrating any set of similarities with these rules. As described in Section 6, we include three instances of this rule, where b is sequence-based, PPI-network-based, or gene ontology-based.
Predicate SimilarDrug a represents a specific drug-drug similarity measure. We consider five instances of rule (6), where a is chemical-based, ligand-based, expression-based, side-effectbased, or annotation-based. Tetrad-based rules. In addition to triads, we also consider more complex templates for reasoning about both drug and target similarities to predict interactions. Specifically, when a drug interacts with a target, we may expect another similar drug to interact with another similar target. Fig. 3 illustrates this hypothesis. We encode this hypothesis using the following tetrad rules:
where a and b are drug-drug or target-target similarity measures as discussed earlier. We include multiple instances of triad and tetrad rules corresponding to the three drug-drug and five target-target similarity measures.
To further enhance our model, we also experiment with an extension of the tetrad-based rules which we call exclusive tetrad rules. The idea behind this extension is to exclusively ground rules for the tetrad structures that do not include any triads inside them:
Negative prior. We also include a negative prior indicating that the Interacts predicate is most likely false, accounting for the natural sparsity in the drug-interaction network. The negative prior rule is as follows:
The similarity predicates SimilarDrug a and SimilarTarget b represent observed values, and the interaction predicate Interacts represents values that are partially observed. These rules all combine to form a complex, structured model that captures a large number of dependencies between unknown Interacts values that we aim to predict. In the next section, we discuss techniques to manage the high complexity of this rich model.
BLOCKING
Because PSL inference considers all possible substitutions for the rules, the number of ground rules can be extremely large. Let jDj denote the number of drugs, jaj the number of different similarities between them, jT j the number of targets, and jbj the number of different similarities between targets. Then each potential link can be involved in OðjDj Â jajÞ instances of rule (6), OðjT j Â jbjÞ instances of rule (5). For tetrad-based rules, the situation is even worse because the number of possible substitutions is even greater. In addition, since there are OðjDj Â jT jÞ potential interactions, the total number of ground rules is OðjDjj T jðjDjjaj þ jT jjbjÞÞ. Running inference on such a massive number of ground rules is too computationally expensive for many practical settings.
To limit the number of ground rules, we prevent some of the rules from being grounded by reducing the number of triads and tetrads that are considered for each potential link. To reduce this number, we essentially ignore some of the less similar drugs and targets pairs. This strategy is reminiscent of blocking [32] , [33] , [34] , which is a term that refers to the process of limiting the number of links considered. Typically, blocking decisions are done using a fast computation to fully avoid the quadratic costs inherent in link prediction settings.
There are several ways to approach blocking in our problem; the most basic strategy simply uses a fixed threshold for all similarities and sets the values below that threshold to zero. However, although the similarities are normalized to ½0; 1, the distribution of the values tends to be highly varied such that a fixed-threshold approach can ignore most of the values in some similarity measures or include most of the values from another. Fig. 4 plots the distribution of similarities in our data set, illustrating the diversity in the shapes of distributions these similarity measures generate.
Another method of blocking chooses a different threshold for each similarity measure. While potentially better than the previous approach, similar issues occur due to variability in individual target and drug similarity distributions. Similarities for each target or for each drug can have highly variable values, and choosing a fixed threshold will include too many similarities for some particular drugs or targets and very few for others. Fig. 5 shows the annotationbased similarity for drugs and demonstrates an instance of this situation.
Instead, our proposed approach uses k-nearestneighbors to ensure that every drug and every target considers at least a few values from each similarity. In this approach, we preserve the k-highest values in each similarity for each drug and each target and set the others to zero. However, depending on the method used for calculating the similarities, there are many cases that similarity values between multiple drugs or targets are the same. Hence, the kth nearest neighbor of a drug or target can have the same similarity as a large set of other drugs or targets. To address the possibility of ties, we consider the drugs or targets with similarities greater than the kth nearest neighbor. In other words, we only include the similarities from k À 1 drugs or targets. Formally, the blocked set of similarity predicates are as follows: 
where is any drug-drug or target-target similarity and x k is the kth nearest neighbor of x i .
COLLECTIVE INFERENCE
Traditional machine learning approaches often predict outputs independently, separating examples into distinct, unrelated instances. For example, in the drug-target interaction prediction setting, the presence or absence of each interaction is determined based on the evidence and independent of the other interactions. However, actual interactions may be interdependent. Classification problems that consider interdependencies are known as collective classification problems [35] . Algorithms that perform collective classification exploit global information propagation through networks defined over the data. Since PSL performs MPE inference on the interpretation I over the whole network, interaction predictions propagate and influence the prediction of other interactions. Thus, PSL models perform collective classification and can reason about new interactions using other predicated interactions.
Specifically, rules (5) and (6) adopt a collective inference approach, using inferred links to imply the existence of other links, that results in global information propagation through the network. Fig. 6 shows a situation where a predicted interaction is used in predicting other interactions.
We designed a model to experiment with the potential detrimental effect of making independent predictions. We use rules analogous to (5) and (6) that do not allow collective inference:
We ground ObservedInteracts with the observed interactions from the data set and use predicate Interacts for predictions. In contrast to rules (5) and (6), here only observed interactions imply the presence of new interactions, whereas in our full joint model, inferred interactions can imply other interactions. Hence, predictions using these new rules are only made based on observed evidence. We report the comparative results of the collective and non-collective models in the experimental analysis section.
EXPERIMENTAL ANALYSIS
We perform an extensive evaluation of our PSL based method on a data set that was obtained from Perlman et al. [8] . We first report on the behavior of the PSL based method 3 for different configurations as follows:
Rule structure. We first compare the effectiveness of triad-based (5 and 6) and tetrad-based rules (7). This study serves as an example to test different domain assumptions for this task. Blocking. We show the effectiveness of our proposed blocking strategy by showing the speedup and performance stability of our blocking method. Weight learning. We measure the effect of weight learning on performance by comparing models with and without weight learning. Collective inference. We show the strength of models with collective inference, by comparing our collective model versus the non-collective version of our model. Combining similarities. Finally, we measure the effectiveness of PSL for combining information from different similarities. In this study, we compare models with all similarities against models using a single similarity.
We then compare the (best) performance of our method against the method of Perlman et al. [8] .
Data Set
We obtained our data set from Perlman et al. [8] . The interactions between drugs and targets are obtained from DrugBank [36] , KEGG Drug [37] , DCDB (Drug Combination database) [38] , and Matador [39] . We also use the same five drug-drug and three target-target similarities used by Perlman et al. [8] .
We filtered the data set to remove the drugs and targets that do not have any computed similarities. The final data set includes 315 drugs, 250 targets, and 1,306 interactions.
Using NodeXL [40] , we calculate graph statistics and visualize the graph. The graph contains 16 connected components, and the largest component includes 518 vertices and 1,280 edges. The average geodesic distance 4 in the graph is 5.31 with a maximum of 15. The vertices' degrees range from 1 to 37, with average of 4.6. Fig. 7 shows an overall visualization of the drug-target interactions in the data set, where drugs are drawn as blue squares and targets as red circles.
This section includes a brief description of the methods used for similarity calculation and how they were computed by Perlman et al. [8] . Drug-drug similarities include the following:
Chemical-based. Using the chemical development kit (CDK) [41] , Perlman et al. [8] computed the hashed fingerprint of each drug based on the canonical SMILES 5 obtained from Drugbank. Considering each fingerprint as a set of elements, they computed the Jaccard similarity of the fingerprints. The Jaccard similarity score between two sets X and Y is
Ligand-based. Drugs' canonical SMILES obtained from Drugbank are compared against a collection of ligand 6 sets using the similarity ensemble approach search tool [4] . A list of relevant protein-receptor families are obtained for each drug, and they computed Jaccard similarity between the corresponding sets of receptor families for each drug pair.
Expression-based. The Spearman rank correlation coefficient of gene expression responses to drugs retrieved from the Connectivity Map Project [16] , [17] are used as a Fig. 6 . Collective inference. Predicted interactions can be used for other inferences using target (a) or drug similarities (b), or both.
3. Our code and data we used for our experiments along with our implementation of the approach from Perlman et al. [8] can be obtained from: https://github.com/shobeir/fakhraei_tcbb2014.
4. The number of edges in a shortest path between two vertices. 5. Simplified Molecular Input Line Entry Specification. 6 . A substance that binds with a biomolecule to serve a biological purpose.
similarity measure between drugs. The Spearman rank correlation coefficient between two sets X and Y is calculated as
where x i and y i are ranked elements of X and Y . Side-effect-based. Similarities between drugs are calculated using the Jaccard score between their common side-effects obtained from SIDER [42] .
Annotation-based. Drugs' ATC codes are obtained from DrugBank and matched against the World Health Organization ATC classification system [43] , where drugs are categorized based on different characteristics. They calculated the similarities using the semantic similarity algorithm of Resnik [44] .
Target-target similarities include the following: Sequence-based. Perlman et al. [8] compute sequencebased similarities using the Smith-Waterman sequence alignment scores, normalized via the method suggested in [23] -which divides the pairwise score by the geometric mean of the alignment scores of each sequence against itself.
Protein-protein interaction network-based. Using an all-pairs shortest path algorithm, they calculated the distance between pairs of genes using their corresponding proteins in the human protein-protein interactions network.
Gene Ontology-based. Using the method of Resnik [44] , they calculated the semantic similarity measure between Gene Ontology annotations, downloaded from UniProt [45] .
Perlman et al. [8] provide more detailed descriptions of these similarities.
Evaluation Criteria
We use 10-fold cross validation, where each fold randomly leaves out 10 percent of the positive and negative (unknown) interactions for testing. We infer interactions and compare against the held-out interactions, measuring performance using the area under the ROC curve (AUC), area under the precision-recall curve (AUPR) of the positive class, and the precision of the top n predictions (P@n) where n ¼ 130 (i.e., the number of positive links held out in each fold) for our evaluations.
AUC is the most commonly reported measure in our related publications and it allows us to compare against the published results of other methods [23] , [8] , [11] on the same data set. Lichtnwalter and Chawla [46] discuss different link prediction evaluation methods.
ROC curves are created by plotting the true positive rate versus the false positive rate at various thresholds [47] . Precision-recall (PR) curves are created by plotting the precision (or positive predictive value) versus the recall (or true positive rate) at various thresholds. ROC and PR curves are visually different but they are highly correlated [48] , and PR curves are more informative in settings with heavy class imbalance, such as link prediction [46] .
Due to this high class imbalance (130 positive to 7,744 negative examples), AUC changes are subtle. We also report AUPR performance and precision of the top 130 predictions which can highlight the importance of each model modification more clearly. This metric is of importance in practice as well, since only the top portion of the predicted interactions are typically actionable for domain experts to further evaluate.
To evaluate our model's performance with cross-validation we used the common method of random sampling of the interactions for hold-outs in each fold. However, we have to assign a value to all the possible grounding to perform weight learning on our PSL model. In order to avoid assigning an arbitrary value to the held-out interactions in each fold we add a dummy predicate (IgnoredInteracts) to the rules only for weight learning. We can avoid grounding of the rules for the held-out interactions using this predicate. For example, we change rule (5) to the following form:
Although this change negatively affects the performance of our model in the cross-validation setting, we believe it provides an unbiased evaluation and avoids an arbitrary assignment to the held-out variables. This is only an artifact of the cross validation evaluation setting.
Analysis Results
We report the results of our five experimental analysis in this section. Rule structure. We first study the effectiveness of each assumption for predictions. We compare the rules based on triads (5 and 6) and the rules based on tetrads (7) . We compare four different settings: the model with only the triad-based rules, the model with only the tetrad-based rules, model with both set of rules, and model with triads and exclusive tetrads. We set the blocking parameter (k) to 5 in all models to control the growth of tetrad-based rules, and we learn the weights using separate held-out set of interactions (equal to the size of cross-validation hold-outs) in each fold.
As Table 1 shows, the rules inspired by triads are more predictive of the interactions compared to the rules that are based on tetrads. It may be the case that, in a collective setting, triad-based rules capture the effect of tetrad-based rules and perform the best. This experiment not only provides insight into the behavior of prediction using triads and tetrads in this domain, but it also demonstrates how we can easily test such assumptions using PSL's flexibility. One can easily generalize this to quickly evaluate different hypothesis about interactions.
Blocking speedup. Next, we study the effect of blocking on performance by varying the number of neighbors (k) and measuring the effect on the PSL model based on the triad rules (5 and 6). We measure the completion time in two settings: first, a setup where we only perform inference, and, second, a setting where we run weight learning and inference. Table 2 lists the average computation time of 10-fold cross-validation experiments on computers with a (2 Â 4) 2.66 GHz Intel processor and 48 GB of RAM. 7 The results show that blocking causes significant improvement in processing time.
Our proposed blocking achieves this speed-up with no significant performance loss. The columns of Table 3 lists the performance as we change the blocking aggressiveness. The insignificant performance change as we block more aggressively suggests that, even with limited number of similarities (i.e., k ¼ 5), PSL can produce accurate predictions. AUPR results in Table 3 (Inference þ W. learning) show that blocking sometimes even helps performance and suggests that the similarities with higher values are most predictive of interactions. These results suggest that, in the drug-target interaction domain, models that rely on 
Inference only 14mins 3h 9.5h Inference + Weight learning 30mins 6h 22h sparse similarities with high value are often more predictive than the ones that include many similarities with low values. Perlman et al. [8] report relatively similar findings with their own model.
Weight learning. We study the effect of weight learning by running experiments under two conditions: with all weights set to 5 (arbitrarily hand-tuned) and with weights being learned from a set of observed interactions. Table 3 lists the performance improvement of the models with weight learning with different k values for blocking.
It is also notable that the performance improvement caused by weight learning is more significant than increasing the number of unblocked similarities used as evidence. Although weight learning improves the results, AUC changes are subtle and AUPR and the precision at the top predictions show the improvement more clearly.
Weight learning performance improvement in AUPR and AUC (for k ¼ 5) is statistically significant (p < 0:005). Fig. 9 illustrates the average relative weights assigned by PSL to triad-based rules for each similarity. We normalize the weights by dividing their value by the learned prior weight, so the resulting quantity represents how much more heavily the rule is weighted than the prior. It is important to note that neither the absolute nor the relative value of the weights provide precise insight into the predictive power of the rules, since the features and predictions are dependent. Nevertheless, they provide some hints as to how the PSL model makes its joint prediction.
An example of low rule weight and high prediction performance is PPI-network-based similarity ( Fig. 9 and Table 4 ), which produces high accuracy for a single-similarity-based model, but has a low normalized weight. A more accurate method of measuring the effectiveness of each rule (and similarity) for prediction is building models with single rules (as described in the next section) and directly measuring their prediction performance. Even in models with single similarities, rule weight does not correlate with prediction power. Fig. 9 also shows the rule weights of models with single similarities, which follows the previous trend.
Combining similarities. We study the effect of incorporating multiple heterogeneous drug-drug and target-target similarities in PSL models. Different similarities can replace SimilarTarget b and SimilarDrug a in rules (5) and (6) as described in previous sections. For each similarity metric, we add an instance of the rule (5) and (6) to the PSL model correspondingly. We study the situation where PSL models predict new interactions using only one drug-drug or target-target similarity versus when they are all combined and the results are shown in Table 4 .
Ligand-based drug-drug similarity and Sequence-based target-target similarity generate the best performance among models using a single similarity. Nevertheless, there is a significant difference between the best single similarity setting (AUC ¼ 0:811 AE 0:026 and AUPR ¼ 0:516 AE 0:062) and the all-similarities-combined setting (AUC ¼ 0:920 AE 0:016 and AUPR ¼ 0:617 AE 0:048). This study clearly shows that considering multiple similarities is critical for optimal prediction accuracy and that PSL can efficiently consider the multi-similarity nature of the problem.
Collective inference. We list the results from comparing the collective versus non-collective PSL models in Table 5 . Due to high class-imbalance, AUC does not reflect the change in performance as well as the other measures. Collective inference performance improvement in AUPR and AUC is statistically significant (p < 0:005). Collective modeling improves the performance in this setting, as it generates a higher overall precision in the top 130 predictions. It is notable that noncollective model is only more effective for the first few predictions. This may be the results of those interactions being predicted based on direct observed evidence. However, collective inference outperforms non-collective setting for higher number of predictions. In addition, collective setting may be more effective when there are more missing links to predict. The significance of collective inference improvement is more clear in Fig. 10b which shows the same experiment with three-fold cross validation and 450 top prediction.
Predictions Evaluation
Finally, we can compare our results with the reported results of other state-of-the-art methods. Perlman et al. [8] report experimental evaluation on the same data set. They report state-of-the-art performance and show that their method significantly outperforms those of Yamanishi et al. [11] and Bleakley and Yamanishi [23] .
Thus, we compare our model's performance with Perlman et al. [8] 10 using the same experimental setting. We report the results based on our folds that contain 130 positives and 7,744 negative links.
11 Table 6 lists the results of different PSL models comparing to the Perlman et al. [8] .
PSL models with triads and blocking parameter k ¼ 5 score a higher AUPR and P@n. This shows that our predictions have higher precision. Although we argue that AUC in such highly imbalanced settings is not as important, we can match the AUC of the previous state-of-the-art by using a more complicated PSL model with triads and exclusive tetrads and using two different blocking parameters of k for each set of rules. Since tetrads generate more groundings, we set k to 5 for tetrads and set k to 15 for triads. Fig. 11 plots the precision of the top 130 predictions of the PSL model with triad rules and k set to 5 in comparison the 9. We performed paired one-tailed t-test on the corresponding values of the 10 folds.
10. We implemented the method of Perlman et al. [8] in correspondence with the authors and reproduced their results. Our implementation of their method is also available for download.
11. The difference between our AUPR results and the ones reported in [8] is due to the down-sampling of the unobserved interactions for testing in their paper. We choose our testing folds based on the real ratio of positives to negatives. predictions of Perlman et al. [8] . The results show that the PSL model with simple, triad-based rules improves the AUPR and P@n prediction performance of the state-of-theart methods. We achieve statistically significant improvements in AUPR using the PSL triad model with k ¼ 5 over the Perlman's method (p < 0:005), and we match the AUC performance of their method using our second PSL model with no significant difference (p > 0:49).
12
New interaction predictions. Additionally, we aimed to evaluate our new interaction predictions by comparing them with new interactions that were not in our initial data set. Using NodeXL's [40] motif clustering tool, we find targets (or drugs) that share several drugs (or targets). One example is PTGS1 and PTGS2, which is shown on the right side of Fig. 7 .
Three unobserved interactions in this structure are Minoxidil-PTGS2, Tiaprofenic acid-PTGS1, and Oxaprozin-PTGS1. Our model ranks Oxaprozin-PTGS1 and Tiaprofenic acid-PTGS1 as the 46th and 158th most probable interactions out of the 77,444 total interactions, placing them in the top 0.2 percentile of all possible interactions. Since the time our data set was collected by Perlman et al. [8] , the online databases have been updated. Examining the latest version of Drugbank, the database now contains these two interactions. 13 Our model ranked Minoxidil-PTGS2 significantly lower than the other two at 1,807, and we could not find any indication in the drug-target interaction data set that this interaction exists. 14 The two targets are shared between all three drugs in this structure, hence, only the target-target similarities were discriminative. The results show that PSL effectively uses different similarities between Oxaprozin and Tiaprofenic acid, and the other targets in the structure to rank their interactions higher than the one involving Minoxidil.
Furthermore, there are 197 interactions that were added to the Drugbank database since our data set was collected. We used these newly reported interactions to further evaluate the performance of our models. We generate 10 folds consisting of these new interactions and samples of the unobserved interactions, to rank these new interactions against all the other possible predictions. Table 7 lists the performance scores of our models and Perlman et al. [8] on the newly reported interactions.
Although our more complex model demonstrates superior numbers on all performance measures, the predictions made by the PSL model with triads and k ¼ 5 are more actionable due to higher precision at the top of the predictions list. That portion of the predictions are the most critical for domain experts to further evaluate. Our more complex PSL model with triads and tetrads achieves higher AUPR due to better recall. Fig. 12 plots the precision of the top 150 prediction of the PSL model with triads with k ¼ 5, the PSL model with triads with k ¼ 15 and exclusive tetrads with k ¼ 5, and Perlman et al. [8] . The simpler PSL model with triads and k ¼ 5 ranks the newly reported interactions higher and performs significantly better than Perlman's method, especially beyond the top 40 predictions. Since there is potential bias in which interactions have been explored in vitro, these results, while encouraging, should be interpreted with discretion.
DISCUSSION AND CONCLUSION
In this paper, we propose a model using probabilistic soft logic for drug target interaction prediction. We propose a blocking method and demonstrate how PSL enables rich, large-scale analysis of drug-target networks, combining similarities and collective inference to produce state-ofthe-art prediction accuracy using an interpretable model. In our experimental evaluation, we isolate the contributions of collective inference, blocking, the combination of similarities, and weight learning to prediction quality. Our results indicate that each of these components plays a positive role, and the high accuracy and efficiency of the full PSL model results from their combination. Bert Huang received the PhD and MSc degree from Columbia University in 2011 for his work on efficient learning and inference using probabilistic models of graph structure, and the BS degree from Brandeis University. He is a postdoctoral research associate in the Department of Computer Science at the University of Maryland. His research investigates topics including structured prediction, statistical relational learning, and computational social science, and his papers have been published at conferences including NIPS, ICML, UAI, and AISTATS.
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